NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

NAUT

Nautilus Biotechnology Inc

Jul 08 • 04:00PM ET

0.7900

Dollar change -0.0060
Percentage change -0.75	%

Healthcare • Biotechnology • USA • NASD

Peers: ILMN GH EXAS TXG PACB TWST QTRX QDEL CDNA OMIC

| Held by: VTI VXF VTWO IWM DFAT DFAC IWN VTWV IWC MSSM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.55	Insider Own	53.43%	Shs Outstand	126.15M	Perf Week	8.98%
Market Cap	99.65M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.16%	Shs Float	58.75M	Perf Month	6.47%
Enterprise Value	-9.82M	PEG	-	EPS next Q	-0.15	Inst Own	28.86%	Short Float	2.10%	Perf Quarter	13.44%
Income	-68.66M	P/S	-	EPS this Y	-7.14%	Inst Trans	-4.28%	Short Ratio	4.01	Perf Half Y	-53.25%
Sales	0.00M	P/B	0.51	EPS next Y	-15.83%	ROA	-26.60%	Short Interest	1.23M	Perf YTD	-52.98%
Book/sh	1.54	P/C	0.72	EPS next 5Y	-5.63%	ROE	-30.93%	52W High	3.09 -74.43%	Perf Year	-65.20%
Cash/sh	1.10	P/FCF	-	EPS past 3/5Y	1.79% -4.55%	ROIC	-31.28%	52W Low	0.66 19.70%	Perf 3Y	-70.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.41% 8.20%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1.20%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.36	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.11	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.36	EPS Q/Q	12.02%	SMA20	6.35%	Beta	1.23	Target Price	2.50
Payout	-	Debt/Eq	0.15	Sales Q/Q	-	SMA50	5.42%	Rel Volume	0.33	Prev Close	0.80
Employees	155	LT Debt/Eq	0.13	Earnings	Apr 29 BMO	SMA200	-50.46%	Avg Volume	307.71K	Price	0.79
IPO	Aug 07, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.96% -	Trades		Volume	101,725	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$1.75
Jun-27-24	Initiated	Guggenheim	Buy	$6
Jun-03-24	Resumed	Jefferies	Hold	$3
Jan-06-22	Initiated	Morgan Stanley	Equal-Weight	$8
Nov-02-21	Initiated	Cowen	Outperform
Aug-04-21	Initiated	Goldman	Neutral	$10
Jul-13-21	Initiated	Jefferies	Buy	$13

May-27-25 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +5.59%
Apr-30-25 03:10AM	Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ... (GuruFocus.com) -6.21%
Apr-29-25 01:01PM	Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript (Seeking Alpha) +7.97%
08:00AM	Nautilus Biotechnology Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 08:00AM	Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 (GlobeNewswire) -6.08%
02:16AM	Loading…
Feb-28-25 02:16AM	Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ... (GuruFocus.com) +11.11%
Feb-27-25 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire) -18.18%
Feb-18-25 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference (GlobeNewswire)
Feb-06-25 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Oct-31-24 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award (GlobeNewswire)
Oct-30-24 08:00AM	Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference (GlobeNewswire)
03:07AM	Nautilus Biotechnology Inc (NAUT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Oct-29-24 08:00AM	Nautilus Biotechnology Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-08-24 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 (GlobeNewswire)
Sep-17-24 08:00AM	Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer (GlobeNewswire)
08:00AM	Loading…
Aug-14-24 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Jul-30-24 08:00AM	Nautilus Biotechnology Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-09-24 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 (GlobeNewswire)
May-23-24 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-03-24 12:00PM	Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know (Zacks)
May-01-24 11:11AM	Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript (Insider Monkey) +9.45%
03:08AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ... (GuruFocus.com)
Apr-30-24 11:54AM	NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024 (InvestorPlace)
08:00AM	Nautilus Biotechnology Reports First Quarter 2024 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected (GuruFocus.com)
Apr-11-24 08:00AM	Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 (GlobeNewswire)
Feb-28-24 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Reports Fiscal Year 2023 Financial Results (GuruFocus.com)
Feb-22-24 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 44 Annual Healthcare Conference (GlobeNewswire)
Feb-07-24 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
08:00AM	Loading…
Nov-30-23 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award (GlobeNewswire)
Nov-01-23 08:05AM	Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development (GlobeNewswire)
Oct-31-23 08:05AM	Nautilus Biotechnology Reports Third Quarter 2023 Financial Results (GlobeNewswire) +9.40%
Oct-11-23 08:05AM	Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 (GlobeNewswire)
Sep-06-23 07:30AM	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-04-23 08:00AM	Nautilus Biotechnology to Participate in Upcoming August Investor Conferences (GlobeNewswire)
Aug-02-23 07:30AM	Nautilus Biotechnology Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-11-23 09:23AM	Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 (GlobeNewswire)
May-24-23 08:05AM	Nautilus Biotechnology to Participate in Upcoming June Investor Conferences (GlobeNewswire)
May-02-23 06:30AM	Nautilus Biotechnology Reports First Quarter 2023 Financial Results (GlobeNewswire) -10.63%
Apr-18-23 04:05PM	Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 (GlobeNewswire) -6.43%
Mar-23-23 08:00AM	Nautilus Biotechnology to Participate in B. Riley Securities Disruptive Biotech Enabling Technologies Proteomics, Virtual Conference (GlobeNewswire)
Mar-07-23 08:00AM	Nautilus Biotechnology Announces First Access Challenge Winners (GlobeNewswire)
Feb-23-23 06:05AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire) -7.00%
Feb-21-23 08:00AM	Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference (GlobeNewswire) -10.31%
Jan-26-23 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (GlobeNewswire)
07:45AM	Nautilus Biotechnology Expands to San Diego (GlobeNewswire)
Jan-19-23 08:00AM	Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) (GlobeNewswire)
Nov-16-22 08:00AM	Nautilus Biotechnology Launches First Access Challenge (GlobeNewswire) -6.47%
Nov-01-22 06:05AM	Nautilus Biotechnology Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-05-22 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 (GlobeNewswire) -7.26%
Sep-23-22 08:00AM	Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit (GlobeNewswire)
Sep-01-22 08:00AM	Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board (GlobeNewswire)
Aug-30-22 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-11-22 06:30AM	Sujal Patel Is The Co-Founder of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) And Just Spent US$146k On Shares (Simply Wall St.)
Aug-02-22 06:48AM	Nautilus Biotechnology Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-01-22 04:05PM	Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development (GlobeNewswire)
Jul-13-22 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022 (GlobeNewswire)
May-12-22 06:28AM	Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares (Simply Wall St.) +6.81%
May-03-22 06:00AM	Nautilus Biotechnology Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-12-22 08:00AM	Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development (GlobeNewswire)
Apr-07-22 08:00AM	Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022 (GlobeNewswire)
Apr-04-22 08:00AM	Nautilus Biotechnology to Present at EuPA and AACR Meetings (GlobeNewswire)
Mar-31-22 04:05PM	Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors (GlobeNewswire)
Mar-05-22 07:22AM	What Percentage Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Do Insiders Own? (Simply Wall St.)
Feb-24-22 06:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results (GlobeNewswire) +8.43%
Feb-16-22 04:05PM	Nautilus to Participate in the 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-02-22 01:38PM	Clarius Group, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, , Vanguard Ultra-Short Bond ... (GuruFocus.com)
Jan-27-22 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 (GlobeNewswire) -6.75%
Dec-16-21 01:07PM	A look at insider stock sales among Portland-area companies in 2021 (Photos) (American City Business Journals)
Dec-05-21 06:39AM	Insider Buying: The Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Co-Founder Just Bought 1.5% More Shares (Simply Wall St.)
Nov-02-21 08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome (GlobeNewswire) +7.17%
06:00AM	Nautilus Biotechnology Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-11-21 08:00AM	Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021 (GlobeNewswire)
Sep-10-21 10:21AM	Do Insiders Own Lots Of Shares In Nautilus Biotechnology, Inc. (NASDAQ:NAUT)? (Simply Wall St.)
Sep-03-21 09:00AM	Nautilus to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-10-21 06:00AM	Nautilus Biotechnology Reports Second Quarter 2021 Financial Results (GlobeNewswire) -5.01%
Aug-09-21 08:00AM	Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development (GlobeNewswire) +6.68%
Jul-13-21 08:00AM	Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021 (GlobeNewswire)
Jun-17-21 07:00AM	Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board (GlobeNewswire)

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mowry Anna	CFO and Treasurer	May 29 '25	Buy	0.77	15,000	11,488	83,000	Jun 02 05:12 PM
Mallick Parag	Chief Scientist	May 08 '25	Buy	0.73	12,000	8,788	20,491,892	May 12 07:19 PM
Mallick Parag	Chief Scientist	May 12 '25	Buy	0.73	1,500	1,098	20,493,392	May 12 07:19 PM
Patel Sujal M	CEO, President, and Secretary	Mar 19 '25	Buy	0.99	53,300	53,028	10,117,788	Mar 21 04:44 PM
Patel Sujal M	CEO, President, and Secretary	Mar 20 '25	Buy	1.00	23,933	23,890	10,141,721	Mar 21 04:44 PM
MARY GODWIN	Officer	Dec 17 '24	Proposed Sale	1.94	38,337	74,263		Dec 17 05:21 PM
MARY GODWIN	Officer	Dec 09 '24	Proposed Sale	2.13	35,000	74,588		Dec 09 04:28 PM
MARY GODWIN	Officer	Dec 03 '24	Proposed Sale	2.20	60,000	131,778		Dec 03 04:28 PM
MARY GODWIN	Officer	Nov 26 '24	Proposed Sale	2.28	60,000	136,512		Nov 26 04:31 PM
MARY GODWIN	Officer	Nov 21 '24	Proposed Sale	2.35	30,000	70,623		Nov 21 05:28 PM
MARY GODWIN	Officer	Nov 19 '24	Proposed Sale	2.27	30,000	68,046		Nov 19 05:00 PM
MARY GODWIN	Officer	Nov 11 '24	Proposed Sale	2.47	40,000	98,884		Nov 12 11:38 AM
MARY ELIZABETH GODWIN	Officer	Nov 08 '24	Proposed Sale	2.51	31,078	78,158		Nov 08 04:37 PM
MARY ELIZABETH GODWIN	Officer	Nov 07 '24	Proposed Sale	2.75	28,922	79,643		Nov 07 04:25 PM
Godwin Mary E.	Senior VP, Operations	Sep 23 '24	Option Exercise	0.46	47,031	21,634	47,031	Sep 25 06:29 PM
Godwin Mary E.	Senior VP, Operations	Sep 23 '24	Sale	2.87	47,031	134,744	0	Sep 25 06:29 PM
MARY ELIZABETH GODWIN	Officer	Sep 23 '24	Proposed Sale	2.86	47,031	134,739		Sep 23 04:58 PM
Godwin Mary E.	Senior VP, Operations	Sep 17 '24	Option Exercise	0.46	35,000	16,100	35,000	Sep 18 06:32 PM
Godwin Mary E.	Senior VP, Operations	Sep 17 '24	Sale	2.85	35,000	99,869	0	Sep 18 06:32 PM
MARY ELIZABETH GODWIN	Officer	Sep 17 '24	Proposed Sale	2.85	35,000	99,866		Sep 17 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAUT

Nautilus Biotechnology Inc

Upgrade your FINVIZ experience